Abbott Laboratories
May 15, 2008
Abbott to Present Data on Novel Cancer Treatments at American Society ...
“Researchers from around the world have requested to study Abbott's Bcl-2 family protein inhibitors, which is an indication of the potential value that ABT-263 might bring to the cancer research field”
Both compounds were discovered by Abbott scientists and are being co-developed by Abbott and Genentech. via Earth Times
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Abbott profit beats Wall Street estimates for 2Q | Fri | Qamile Stema | 13 |
| FDA panel opposes Depakote warning | Jul 11 | Deeptoad | 1 |
| Sugar in popular Similac Organic baby formula r... | Jun '08 | Wendy | 5 |
| Mylan, Abbott settle anti-seizure drug dispute | Jun '08 | Jim | 1 |
| Abbott drugs in FDA risk reviews | Jun '08 | Corby | 2 |
| Arthritis drugs investigated for link to cancer | Jun '08 | RAG | 4 |
| Vacancies edging up for area's retailers -- Ban... | Jun '08 | speculator | 1 |
Most Popular
